(NASDAQ: IRMD) Iradimed's forecast annual revenue growth rate of 15.4% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 30.35%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 1,472.57%.
Iradimed's revenue in 2025 is $80,511,268.On average, 4 Wall Street analysts forecast IRMD's revenue for 2026 to be $1,181,948,046, with the lowest IRMD revenue forecast at $1,134,218,269, and the highest IRMD revenue forecast at $1,218,177,899.
In 2027, IRMD is forecast to generate $1,225,912,361 in revenue, with the lowest revenue forecast at $1,177,826,392 and the highest revenue forecast at $1,261,964,118.